This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Castaño, E.
Right arrow Articles by Dynlacht, B. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Castaño, E.
Right arrow Articles by Dynlacht, B. D.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, September 1998, p. 5380-5391, Vol. 18, No. 9
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Dual Cyclin-Binding Domains Are Required for p107 To Function as a Kinase Inhibitor

Enrique Castaño, Yelena Kleyner, and Brian David Dynlacht*

Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts 02138

Received 5 March 1998/Returned for modification 22 April 1998/Accepted 1 June 1998

The retinoblastoma (pRB) family of proteins includes three proteins known to suppress growth of mammalian cells. Previously we had found that growth suppression by two of these proteins, p107 and p130, could result from the inhibition of associated cyclin-dependent kinases (cdks). One important unresolved issue, however, is the mechanism through which inhibition occurs. Here we present in vivo and in vitro evidence to suggest that p107 is a bona fide inhibitor of both cyclin A-cdk2 and cyclin E-cdk2 that exhibits an inhibitory constant (Ki) comparable to that of the cdk inhibitor p21/WAF1. In contrast, pRB is unable to inhibit cdks. Further reminiscent of p21, a second cyclin-binding site was mapped to the amino-terminal portions of p107 and p130. This amino-terminal domain is capable of inhibiting cyclin-cdk2 complexes, although it is not a potent substrate for these kinases. In contrast, a carboxy-terminal fragment of p107 that contains the previously identified cyclin-binding domain serves as an excellent kinase substrate although it is unable to inhibit either kinase. Clustered point mutations suggest that the amino-terminal domain is functionally important for cyclin binding and growth suppression. Moreover, peptides spanning the cyclin-binding region are capable of interfering with p107 binding to cyclin-cdk2 complexes and kinase inhibition. Our ability to distinguish between p107 and p130 as inhibitors rather than simple substrates suggests that these proteins may represent true inhibitors of cdks.

* Corresponding author. Mailing address: Harvard University, Department of Molecular and Cellular Biology, 16 Divinity Ave., Cambridge, MA 02138. Phone: (617) 496-1308/1351. Fax: (617) 496-1391. E-mail: dynlacht{at}biosun.harvard.edu.

Molecular and Cellular Biology, September 1998, p. 5380-5391, Vol. 18, No. 9
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Sabelli, P. A., Hoerster, G., Lizarraga, L. E., Brown, S. W., Gordon-Kamm, W. J., Larkins, B. A. (2009). Positive regulation of minichromosome maintenance gene expression, DNA replication, and cell transformation by a plant retinoblastoma gene. Proc. Natl. Acad. Sci. USA 106: 4042-4047 [Abstract] [Full Text]  
  • James, M. K., Ray, A., Leznova, D., Blain, S. W. (2008). Differential Modification of p27Kip1 Controls Its Cyclin D-cdk4 Inhibitory Activity. Mol. Cell. Biol. 28: 498-510 [Abstract] [Full Text]  
  • Ji, P., Sun, D., Wang, H., Bauzon, F., Zhu, L. (2007). Disrupting Skp2-cyclin A interaction with a blocking peptide induces selective cancer cell killing. Molecular Cancer Therapeutics 6: 684-691 [Abstract] [Full Text]  
  • Soeiro, I., Mohamedali, A., Romanska, H. M., Lea, N. C., Child, E. S., Glassford, J., Orr, S. J., Roberts, C., Naresh, K. N., Lalani, E.-N., Mann, D. J., Watson, R. J., Thomas, N. S. B., Lam, E. W.-F. (2006). p27Kip1 and p130 Cooperate To Regulate Hematopoietic Cell Proliferation In Vivo.. Mol. Cell. Biol. 26: 6170-6184 [Abstract] [Full Text]  
  • Sabelli, P. A., Dante, R. A., Leiva-Neto, J. T., Jung, R., Gordon-Kamm, W. J., Larkins, B. A. (2005). Inaugural Article: RBR3, a member of the retinoblastoma-related family from maize, is regulated by the RBR1/E2F pathway. Proc. Natl. Acad. Sci. USA 102: 13005-13012 [Abstract] [Full Text]  
  • Rodier, G., Makris, C., Coulombe, P., Scime, A., Nakayama, K., Nakayama, K. I., Meloche, S. (2005). p107 inhibits G1 to S phase progression by down-regulating expression of the F-box protein Skp2. JCB 168: 55-66 [Abstract] [Full Text]  
  • Klausen, P., Bjerregaard, M. D., Borregaard, N., Cowland, J. B. (2004). End-stage differentiation of neutrophil granulocytes in vivo is accompanied by up-regulation of p27kip1 and down-regulation of CDK2, CDK4, and CDK6. J. Leukoc. Biol. 75: 569-578 [Abstract] [Full Text]  
  • Zhang, Z., Huong, S.-M., Wang, X., Huang, D. Y., Huang, E.-S. (2003). Interactions between Human Cytomegalovirus IE1-72 and Cellular p107: Functional Domains and Mechanisms of Up-Regulation of Cyclin E/cdk2 Kinase Activity. J. Virol. 77: 12660-12670 [Abstract] [Full Text]  
  • Joaquin, M., Watson, R. J. (2003). The Cell Cycle-regulated B-Myb Transcription Factor Overcomes Cyclin-dependent Kinase Inhibitory Activity of p57KIP2 by Interacting with Its Cyclin-binding Domain. J. Biol. Chem. 278: 44255-44264 [Abstract] [Full Text]  
  • Mitchell, P. J., Perez-Nadales, E., Malcolm, D. S., Lloyd, A. C. (2003). Dissecting the Contribution of p16INK4A and the Rb Family to the Ras Transformed Phenotype. Mol. Cell. Biol. 23: 2530-2542 [Abstract] [Full Text]  
  • Helt, A.-M., Galloway, D. A. (2003). Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. Carcinogenesis 24: 159-169 [Abstract] [Full Text]  
  • Tedesco, D., Lukas, J., Reed, S. I. (2002). The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCFSkp2. Genes Dev. 16: 2946-2957 [Abstract] [Full Text]  
  • Olashaw, N., Pledger, W. J. (2002). Paradigms of Growth Control: Relation to Cdk Activation. Sci Signal 2002: re7-re7 [Abstract] [Full Text]  
  • Leng, X., Noble, M., Adams, P. D., Qin, J., Harper, J. W. (2002). Reversal of Growth Suppression by p107 via Direct Phosphorylation by Cyclin D1/Cyclin-Dependent Kinase 4. Mol. Cell. Biol. 22: 2242-2254 [Abstract] [Full Text]  
  • Ehmann, G. L., Burnett, H. A., Bachenheimer, S. L. (2001). Pocket Protein p130/Rb2 Is Required for Efficient Herpes Simplex Virus Type 1 Gene Expression and Viral Replication. J. Virol. 75: 7149-7160 [Abstract] [Full Text]  
  • Alexander, K., Hinds, P. W. (2001). Requirement for p27KIP1 in Retinoblastoma Protein-Mediated Senescence. Mol. Cell. Biol. 21: 3616-3631 [Abstract] [Full Text]  
  • Vairo, G., Soos, T. J., Upton, T. M., Zalvide, J., DeCaprio, J. A., Ewen, M. E., Koff, A., Adams, J. M. (2000). Bcl-2 Retards Cell Cycle Entry through p27Kip1, pRB Relative p130, and Altered E2F Regulation. Mol. Cell. Biol. 20: 4745-4753 [Abstract] [Full Text]  
  • Cross, F. R., Jacobson, M. D. (2000). Conservation and Function of a Potential Substrate-Binding Domain in the Yeast Clb5 B-Type Cyclin. Mol. Cell. Biol. 20: 4782-4790 [Abstract] [Full Text]  
  • McElroy, A. K., Dwarakanath, R. S., Spector, D. H. (2000). Dysregulation of Cyclin E Gene Expression in Human Cytomegalovirus-Infected Cells Requires Viral Early Gene Expression and Is Associated with Changes in the Rb-Related Protein p130. J. Virol. 74: 4192-4206 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»